Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2022-02-02 00:00:00 ET · period of report 2022-01-31 · accession 0001628280-22-001707 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-02 | 2022-01-31 | CLOV | Reynoso Jamie L. | COO | A - Grant | $0.00 | +15.8K | 236.6K | +7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-01-31 | A | A | 15,771 | $0.00 | 236,591 | D | — | — | (F1) Represents shares of Class A common stock underlying time-based restricted stock units ("RSUs") that vest in three equal annual installments on January 31, 2022, January 1, 2023 and January 1, 2024. On July 16, 2021, the Reporting Person was granted a performance-based restricted stock unit award, and on January 31, 2022, the Talent and Compensation Committee of the Board of Directors certified the achievement of certain of the performance criteria, resulting in the grant of the RSUs. |